Subscribe To
The stock that tripled in a day
Texas-based biotechnology company Reata pharmaceuticals, Inc. (NASDAQ:RETA) lulled shareholders to slee...
March 7, 2023, 6:55 am
Dupixent® (dupilumab) application for treatment of chronic spontaneous urticaria (csu) in adults and adolescents aged 12 years and older accepted for fda review
More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by antihistamines TARRYTOWN, N.Y. and PARIS, March 07, 2023 (GLOB...
March 7, 2023, 6:00 am
Avid bioservices to report financial results for third quarter of fiscal year 2023 after market close on march 13, 2023
TUSTIN, Calif., March 06, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing...
March 6, 2023, 9:05 pm
Cyclacel pharmaceuticals, inc. (cycc) q4 2022 earnings call transcript
Cyclacel pharmaceuticals, Inc. (NASDAQ:CYCC ) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ET...
March 6, 2023, 9:04 pm
Eloxx pharmaceuticals to present at the oppenheimer 33rd annual healthcare conference
WATERTOWN, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Eloxx pharmaceuticals, Inc. (NASDAQ: ELOX), a lead...
March 6, 2023, 4:10 pm
Savara to present at the oppenheimer 33rd annual healthcare conference
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company ...
March 6, 2023, 4:05 pm
Nurix therapeutics to present at the oppenheimer 33rd annual healthcare conference
SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage bio...
March 6, 2023, 4:01 pm
Eli lilly is cutting insulin prices and capping copays at $35 – 5 questions answered
By Dana Goldman, University of Southern California and Karen Van Nuys, University of Southern California pharm...
March 6, 2023, 2:00 pm
Mindset pharma and pharmala complete first sale of pharmaceutical-grade psilocybin into growing australian market via sales partnership
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) said PharmAla Biotech (CSE:MDMA) Holdings Inc has completed the first sale of a quantity of Mindset's ...
March 6, 2023, 8:08 am
Spero therapeutics to provide business update and report fourth quarter and full year 2022 financial results on monday, march 13, 2023
CAMBRIDGE, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage bio...
March 6, 2023, 8:05 am
Acrivon therapeutics to present at the oppenheimer 33rd annual healthcare conference
WATERTOWN, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinic...
March 6, 2023, 8:00 am
Athira pharma to present data supporting therapeutic potential of enhancing hgf/met neurotrophic system at upcoming scientific conferences
BOTHELL, Wash., March 06, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage bio...
March 6, 2023, 7:00 am
Reata pharmaceuticals announces participation in the barclays global healthcare conference
PLANO, Texas--(BUSINESS WIRE)--Reata pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,...
March 6, 2023, 6:40 am
2 reasons to buy moderna stock, and 1 reason to sell
Moderna's multi-year run of earning billions from its COVID-19 vaccine is winding down. It still has a massive pipeline of other ...
March 6, 2023, 5:31 am
Additional data on lumos oragrowth trials presented at international meeting of pediatric endocrinology
Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data Analysis Baseline Characteristi...
March 5, 2023, 7:00 pm
Better generics pharmaceutical stock: teva or viatris?
Teva is the world's largest maker of generic drugs. Viatris offers an above-average dividend yield....
March 5, 2023, 11:28 am
89bio presents new analysis of data from phase 2 entrigue trial of pegozafermin in patients with severe hypertriglyceridemia (shtg) at american college of cardiology’s annual scientific session togeth
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG ...
March 4, 2023, 6:30 pm
89bio presents new analysis of data from phase 2 entrigue trial of pegozafermin in patients with severe hypertriglyceridemia (shtg) at american college of cardiology’s annual scientific session togeth
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG ...
March 4, 2023, 6:30 pm
89bio presents new analysis of data from phase 2 entrigue trial of pegozafermin in patients with severe hypertriglyceridemia (shtg) at american college of cardiology’s annual scientific session togeth
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG ...
March 4, 2023, 6:30 pm
89bio presents new analysis of data from phase 2 entrigue trial of pegozafermin in patients with severe hypertriglyceridemia (shtg) at american college of cardiology’s annual scientific session togeth
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG ...
March 4, 2023, 6:30 pm